Accenture CEO Julie Sweet reveals her key interview question for potential employees. In a recent podcast with Norges Bank Investment Management CEO Nicolai Tangen, Sweet explained how she ...

CEO of Accenture Julie Sweet. 34,691 people played the daily Crossword recently. Can you solve it faster than others?34,691 people played the daily Crossword recently. Can you solve it faster than ...

Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff that “the prognosis from my doctor is excellent; the cancer was caught ...

Accenture CEO Julie Sweet has been diagnosed with early-stage breast cancer. With an excellent prognosis and a curable condition, she will undergo surgery and radiation treatment while continuing ...

Today, Accenture plc (NYSE:ACN), a $243 billion market cap technology consulting giant, disclosed an update on the health of Julie Sweet, the company's Chair and Chief Executive Officer.

Accenture sent a memo to employees on Thursday announcing that it's ending its corporate DEI policies and diversity goals, ...

Accenture Chief Executive Officer Julie Sweet has been diagnosed with early-stage breast cancer and the treatment is likely to last 12-16 weeks, Moneycontrol has learnt. “I was very recently ...

Analyst notes from JP Morgan, Goldman Sachs, Wedbush. Plus: All the news and watercooler chat from Fortune. Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come ...

Today, Accenture plc (NYSE:ACN), a $243 billion market cap technology consulting giant, disclosed an update on the health of Julie Sweet, the company’s Chair and Chief Executive Officer. In a message ...